In a 68-year-old female with febrile episodes, a large solid left renal mass invading the perirenal fascia and left adrenal gland, pyuria, leukocytosis with neutrophilia, normal chest X‑ray, and mildly impaired renal function, what is the likely impression and appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Impression and Management

This presentation is most consistent with locally advanced renal cell carcinoma (RCC) with superimposed infection (pyonephrosis or perinephric abscess), requiring urgent broad-spectrum antibiotics, blood and urine cultures, and multidisciplinary oncologic evaluation for nephrectomy once infection is controlled.

Clinical Impression

The combination of a large solid renal mass invading perirenal fascia and adrenal gland in a 68-year-old woman strongly suggests locally advanced RCC (likely cT3-T4) 1, 2. However, the acute febrile presentation with marked pyuria (18-23 WBC/hpf) and leukocytosis (WBC 16,000 with 91% neutrophils) indicates a concurrent infectious complication—either pyonephrosis within an obstructed system or a perinephric abscess.

Key Diagnostic Considerations:

The differential diagnosis includes:

  • Primary diagnosis: Locally advanced RCC with superimposed infection (most likely)
  • Alternative inflammatory mimics to consider:
    • Xanthogranulomatous pyelonephritis (XGP)—can present identically with fever, mass, leukocytosis, and invasion of perirenal fat 3, 4
    • Upper tract urothelial carcinoma with parenchymal invasion 5, 6
    • Renal actinomycosis or other chronic infections 7

Critical distinguishing features: RCC commonly presents with paraneoplastic fever (Stauffer's syndrome, unexplained fever) 1, but the marked pyuria and neutrophilia here suggest true infection rather than purely paraneoplastic phenomena. XGP typically shows a non-functioning kidney on imaging and may have staghorn calculi 3, 4, though this isn't universal.

Immediate Management Algorithm

Step 1: Stabilize and Treat Infection (First 24-48 hours)

  • Obtain cultures immediately: Blood cultures (×2 sets) and urine culture before antibiotics
  • Start empiric broad-spectrum antibiotics: Cover gram-negatives and enterococci (e.g., piperacillin-tazobactam 4.5g IV q6h or ceftriaxone 2g IV daily plus metronidazole)
  • Monitor renal function closely: Given mildly elevated creatinine and potential sepsis
  • Assess for sepsis: Check lactate, monitor vital signs, ensure adequate fluid resuscitation

Step 2: Complete Staging Workup (Within 48-72 hours)

Per current RCC guidelines 2:

  • Contrast-enhanced CT chest/abdomen/pelvis (if not already done with adequate protocol): Essential for staging, assessing venous involvement, lymphadenopathy, and metastases 1, 2
  • Laboratory prognostic markers: Serum calcium (corrected), LDH, CRP, hemoglobin—these inform risk stratification 1
  • Renal mass biopsy: Strongly recommended before definitive treatment 1, 2
    • Core needle biopsy has 86-100% sensitivity and 98-100% specificity 2
    • Distinguishes RCC from inflammatory mimics (XGP, actinomycosis) and benign lesions
    • Provides histologic subtype and grade for treatment planning
    • Tumor seeding risk is exceptional 1
    • Perform after infection controlled to reduce procedural risk

Step 3: Definitive Treatment Planning (After Infection Control)

Once afebrile and infection treated (typically 7-14 days of antibiotics):

If Biopsy Confirms RCC:

  • Radical nephrectomy with adrenalectomy is indicated for locally advanced disease invading perirenal fascia and adrenal 1, 2
  • Surgical approach depends on:
    • Extent of venous involvement (assess for tumor thrombus with MRI if needed)
    • Lymph node status
    • Performance status and contralateral kidney function
  • Consider neoadjuvant systemic therapy in select cases of borderline resectable disease (emerging data, not yet standard)

If Biopsy Shows Inflammatory Process (XGP, actinomycosis):

  • Nephrectomy remains treatment of choice for XGP 3, 4
  • Prolonged antibiotic therapy (4-6 weeks) for actinomycosis 7

Critical Pitfalls to Avoid

  1. Don't assume all renal masses with fever are infected RCC: XGP can be radiographically and clinically indistinguishable 3. The biopsy is crucial.

  2. Don't delay infection treatment: Sepsis from pyonephrosis can be life-threatening. Antibiotics and source control (drainage if abscess identified) take priority over oncologic workup.

  3. Don't skip chest imaging: Even though CXR is normal, contrast-enhanced chest CT is mandatory for RCC staging 2. Lung metastases may not be visible on plain radiography.

  4. Don't perform nephrectomy during active infection: Increased surgical morbidity and mortality. Control infection first.

  5. Recognize paraneoplastic vs. infectious fever: RCC can cause fever without infection 1, but the marked pyuria here mandates treating as infection until proven otherwise.

Prognostic Considerations

Locally advanced RCC (T3-T4) with adrenal involvement carries significant risk for occult metastatic disease. The elevated neutrophil count and inflammatory markers may also indicate poor prognostic features beyond staging 1. Post-nephrectomy surveillance and consideration of adjuvant systemic therapy trials should be discussed with medical oncology.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.